| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 9.11▲ | 9.08▲ | 9.07▲ | 9.08▼ | 7.76▲ |
| MA10 | 9.09▲ | 9.04▲ | 8.99▲ | 8.82▲ | 6.28▲ |
| MA20 | 9.05▲ | 9.02▲ | 9.14▼ | 7.84▲ | 5.38▲ |
| MA50 | 9.05▲ | 9.09▲ | 8.84▲ | 6.04▲ | 7.68▲ |
| MA100 | 9.13▲ | 8.74▲ | 8.09▲ | 5.54▲ | 10.62▼ |
| MA200 | 8.81▲ | 7.64▲ | 6.69▲ | 7.26▲ | 304.52▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.013▲ | 0.011▲ | -0.023▼ | 0.048▲ | 0.762▲ |
| RSI | 56.565▲ | 53.780▲ | 54.369▲ | 71.440▲ | 62.834▲ |
| STOCH | 83.353▲ | 79.832 | 69.341 | 70.738 | 86.708▲ |
| WILL %R | 0.000▲ | 0.000▲ | -39.175 | -23.433▲ | -13.251▲ |
| CCI | 106.051▲ | 133.333▲ | 62.307 | 83.851 | 160.383▲ |
|
Friday, August 15, 2025 05:46 AM
Avalo Therapeutics (NASDAQ:AVTX) stock rises as Cantor Fitzgerald launches coverage with an Overweight rating, highlighting its lead asset, AVTX-009. Read more here.
|
|
Thursday, August 07, 2025 05:32 AM
Topline data from Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa expected mid-2026Rita Jain, M.D. appointed to Board of DirectorsCash and short-term investments of appro ...
|
|
Thursday, August 07, 2025 04:24 AM
Topline data from Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa expected mid-2026Rita Jain, M.D. appointed to Board of DirectorsCash and short-term investments of ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 15/08/25 | 9.60 | 9.80 | 8.8032 | 9.02 | 176,007 |
| 14/08/25 | 8.92 | 9.00 | 8.5846 | 8.95 | 944,343 |
| 13/08/25 | 9.47 | 9.70 | 8.93 | 9.075 | 105,389 |
| 12/08/25 | 9.01 | 9.88 | 8.51 | 9.36 | 148,096 |
| 11/08/25 | 8.93 | 9.70 | 8.29 | 9.005 | 213,813 |
| 08/08/25 | 8.76 | 9.25 | 8.37 | 8.93 | 392,508 |
| 07/08/25 | 8.35 | 8.7899 | 8.0101 | 8.35 | 857,068 |
| 06/08/25 | 8.29 | 8.63 | 8.0026 | 8.31 | 186,633 |
| 05/08/25 | 9.14 | 9.20 | 7.87 | 8.20 | 1,547,005 |
| 04/08/25 | 7.98 | 9.4099 | 7.95 | 8.97 | 247,647 |
|
|
||||
|
|
||||
|
|